BLUEBIRD STRATEGIES

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · posted Jul 6, 2026

Lobbying activity 1

Health Issues

Issues related to CMS drug pricing, FDA drug regulations, biosimilar coverage and reimbursement

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem